Profile
RDY ZTS HLN TAK TEVA VTRS
Company Name Dr. Reddy's Laboratories Limited Zoetis Inc. Haleon plc Takeda Pharmaceutical Company Limited Teva Pharmaceutical Industries Limited Viatris Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $13.04B $86.09B $47.26B $45.53B $19.82B $13.83B
Employees 27.05K 14.10K 25.41K 49.28K 35.00K 33.00K
CEO Mr. Erez Israeli M.B.A. Ms. Kristin C. Peck Mr. Brian James McNamara Mr. Christophe Weber Mr. Richard D. Francis Mr. Scott Andrew Smith
Ratings
RDY ZTS HLN TAK TEVA VTRS
Quant Rating Score 3 3 3 3 1 2
Quant Rating Neutral Neutral Neutral Neutral Strong Sell Sell
Trading
RDY ZTS HLN TAK TEVA VTRS
Last Close $78.27 $190.03 $10.37 $14.43 $17.49 $11.59
High 52 $84.21 $200.09 $10.69 $15.43 $18.96 $13.53
Low 52 $64.25 $145.54 $7.78 $12.6 $8.12 $8.77
Price vs. 52 Week High -7.05 % -5.03 % -2.99 % -6.48 % -7.75 % -14.34 %
Price vs. 52 Week Low 21.82 % 30.57 % 33.29 % 14.52 % 115.39 % 32.16 %
Total Return
RDY ZTS HLN TAK TEVA VTRS
1 Month Return -1.17 % 0.42 % 0.39 % -2.57 % -3.26 % 2.84 %
3 Month Return 0.29 % 8.61 % 22.43 % 9.24 % 6.65 % 12.31 %
6 Month Return 6.11 % 14.57 % 25.09 % 5.95 % 22.74 % -1.78 %
9 Month Return 10.97 % -2.47 % 22.72 % -1.97 % 54.37 % -3.26 %
YTD Return 12.49 % -3.72 % 26 % 1.12 % 67.53 % 7.02 %
1 Year Return 18.04 % 8.23 % 22.65 % -4.82 % 85.67 % 19.98 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
RDY ZTS HLN TAK TEVA VTRS
Dividend Yield Percentage (TTM) 0.61 % 0.88 % 2 % 2.08 % - 4.14 %
Dividend Paid and Capex Coverage Ration (TTM) 1.51 % 2.01 % - 1.21 % 3.64 % 2.31 %
Dividend Per Share (TTM) 0.48 % 1.67 % 0.16 % 0.3 % - 0.48 %
Payout Ratio (TTM) 11.96 % 31.57 % - 196.47 % - -89.13 %
Growth
RDY ZTS HLN TAK TEVA VTRS
Asset Growth 20.03 % -4.28 % -2.18 % 8.25 % -1.2 % -4.67 %
Gross Profit Growth -19.39 % 3.7 % 5.85 % -16.6 % 9.64 % 1.09 %
Revenue Growth 13.54 % 5.74 % 4.09 % 5.87 % 6.16 % -5.42 %
Revenue 3 Year 46.66 % 31.98 % 13.9 % 33.13 % -6.92 % -35.51 %
Revenue 5 Year 80.93 % 53.64 % 32.87 % 149.89 % -23.33 % -42.34 %
Revenue 10 Year 115.85 % 103.1 % 32.87 % 154.38 % -40.82 % -28.91 %
EBIT Growth -29.66 % 6.27 % 37.26 % 7.34 % -84.52 % 390.23 %
Net Income Growth 23.56 % 10.88 % -1.04 % -54.56 % 76.24 % -97.37 %
Net Income 3 Yeari Growth Per Share 221.96 % 47.55 % -8.67 % -61.74 % 86.29 % 104.09 %
Net Income 5 Yeari Growth Per Share 195.42 % 71.94 % 59.66 % 62.27 % 76.28 % -93.35 %
Net Income 10 Yeari Growth Per Share 164.53 % 404.24 % 59.66 % 36.33 % -133.42 % -97.2 %
Operating Income Growth -29.66 % 6.27 % 37.26 % 7.34 % -84.52 % 390.23 %
Operating Cash Flow Growth (CFG) -22.83 % 23.06 % -16.48 % -34.47 % -13.96 % -5.18 %
Operating 3 Year CFG 26.83 % 14.12 % 22.08 % -36.76 % 10.09 % 13.84 %
Operating 5 Year CFG 57.83 % 37.69 % 118.54 % 139.61 % -48.98 % -48.75 %
Operating 10 Year CFG 138.55 % 274.61 % 118.54 % 335.67 % -67.94 % -19.21 %
EPS Growth 23.48 % 12.64 % - -54.92 % 76.42 % -97.33 %
EPS Diluted Growth 23.51 % 12.92 % - -54.86 % 76.42 % -97.35 %
Book Value Per Share 20.22 % 15.25 % 1.35 % 13.54 % -7.25 % -1.92 %
Share Holder 3 Year Equity Growth Per Share 59.8 % 36.7 % -36.6 % 40.38 % -26.74 % -55.34 %
Share Holder 5 Year Equity Growth Per Share 99.54 % 139.55 % -39.41 % 73.27 % -53.44 % -27.89 %
Share Holder 10 Year Equity Growth Per Share 215.75 % 476.36 % -39.41 % 197.1 % -74.76 % 122.18 %
Dividend Per Share Growth 33.23 % 15.15 % -85.58 % 1.95 % - -0.06 %
Dividend 3 Year Growth Per Share 59.78 % 87.76 % -83.69 % 1.19 % - -
Dividend 5 Year Growth Per Share 65.64 % 198.29 % -66.42 % 146.94 % -100 % -
Dividend 10 Year Growth Per Share 127.6 % 665.58 % -66.42 % 103.93 % -100 % -
Debt Growth 48.6 % -15.91 % -9.43 % 24.67 % -6.53 % -4.64 %
Free Cash Flow Growth -55.02 % 22.25 % -20.06 % -53.54 % -19.19 % -7.35 %
Updated On 31 Mar 2024 31 Dec 2023 31 Dec 2023 31 Mar 2024 31 Dec 2023 31 Dec 2023
Profitability
RDY ZTS HLN TAK TEVA VTRS
Gross Profit Margin TTM 59.06 % 68.75 % 59.91 % 62.49 % 49.52 % 41.22 %
Return on Assets TTM 13.38 % 16.55 % 3.26 % 0.92 % -1.15 % -1.43 %
Return on Equity TTM 20.28 % 46.65 % 6.54 % 2.08 % -6.77 % -3.2 %
Return on Capital Employed TTM 21.91 % 26.29 % 7.25 % 3.36 % 9 % 3.69 %
Net Income Per EBT TTM 76.95 % 81 % 65.38 % 292.06 % 287.88 % 101.02 %
EBT Per Ebit TTM 106.46 % 88.99 % 82.66 % 11.1 % -6.48 % -46.15 %
EBIT Per Revenue TTM 23.52 % 36.48 % 17.88 % 10.48 % 15.62 % 9.12 %
Cash Flow To Debt Ratio TTM 139.13 % 39.73 % - 14.18 % 9.55 % 13.42 %
Receivables Turnover TTM 3.56 6.45 5.27 5.71 4.33 3.94
Payables Turnover TTM 3.46 6.63 1.25 3.53 3.48 6.47
Inventory Turnover TTM 1.72 1.14 3.09 1.3 2.1 2.27
Fixed Asset Turnover TTM 359.09 % 260.52 % 604.62 % 211.62 % 274.84 % 518.04 %
Asset Turnover TTM 69.47 % 62.94 % 33.71 % 27.2 % 39.43 % 33.55 %
Operating Cash Flow Per Share TTM 255.89 5.97 - 495.38 1.57 1.94
Free Cash Flow Per Share TTM 125.86 4.62 - 272.75 1.14 1.58
Cash Per Share TTM 56734.81 % 345.55 % 5.72 % 54665.66 % 199.29 % 84.74 %
Operating Cash Flow Sales Ratio TTM 14.79 % 30.49 % - 17.61 % 10.92 % 15.17 %
Free Cash Flow Operating Cash Flow Ratio TTM 49.18 % 77.37 % - 55.06 % 72.53 % 81.65 %
Cash Flow Coverage Ratios TTM 139.13 % 39.73 % - 14.18 % 9.55 % 13.42 %
Price To Free Cash Flows Ratio TTM 52.16 40.94 - 15.82 15.35 7.34
Price To Operating Cash Flows Ratio TTM 25.68 31.85 - 4.33 11.13 5.98
Price Cash Flow Ratio TTM 25.68 31.85 - 4.33 11.13 5.98
Income Statement (TTM)
RDY ZTS HLN TAK TEVA VTRS
Revenue $279.16B $8.54B $11.3B $4263.76B $15.85B $15.38B
Gross Profit $163.61B $5.83B $6.96B $2321.31B $7.65B $6.57B
Gross Profit Ratio 58.61% 68.28% 61.6% 54.44% 48.25% 42.7%
EBITDA $82.57B $3.56B $2.81B $1254.52B $4.27B $4.73B
Net Income $55.68B $2.34B $1.05B $144.07B $-0.56B $0.05B
EPS Diluted 334.59 5.07 0.11 91.16 -0.5 0.05
Balance Sheet (MRQ)
RDY ZTS HLN TAK TEVA VTRS
Long Term Debt $5.99B $6.56B $8.8B $4476.5B $18.48B $16.19B
Total Liabilities $106.97B $9.3B $17.33B $7834.79B $35.35B $27.22B
Total Equity $280.55B $4.99B $16.73B $7274.01B $8.13B $20.47B
Total Investments $79.62B $0.02B $0.07B $683.22B $0.01B $1.23B
Total Debt $20.02B $6.8B $9.46B $5463.39B $20.15B $18.38B
Total Assets $387.52B $14.29B $34.06B $15108.79B $43.48B $47.69B
Cash Flow Statement (TTM)
RDY ZTS HLN TAK TEVA VTRS
Net Income $55.68B $2.34B $1.05B $144.07B $-0.62B $0.05B
Inventory $-18.45B $-0.36B $-0.13B $-115.74B $-0.15B $-0.61B
Dividends Paid $-6.65B $-0.69B $-0.39B $-287.19B $0B $-0.58B
Operating Cash Flow $45.43B $2.35B $1.72B $640.32B $1.37B $2.8B
Capital Expenditure $-27.44B $-0.73B $-0.34B $-480.73B $-0.53B $-0.47B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 5.5
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.07
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 12.3
ALVOW Alvotech 2.98
AMPH Amphastar Pharmaceuticals, Inc. 46.72
AMRX Amneal Pharmaceuticals, Inc. 8.65
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 57.83
AQST Aquestive Therapeutics, Inc. 4.95
ASRT Assertio Holdings, Inc. 1.14
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 13.09
AYTU Aytu BioPharma, Inc. 2.35
ETFs With Exposure to RDY
Ticker ETF Name Weight Percentage Price
VWO Vanguard Emerging Markets Stock Index Fund 0.03 49.06
VEU Vanguard FTSE All-World ex-US Index Fund 0.01 62.93
VXUS Vanguard Total Intl Stock Idx Fund 0 64.61
CWI SPDR MSCI ACWI ex-US ETF 0.084642 30.44
SPEM SPDR Portfolio Emerging Markets ETF 0.164748 42.34
EELV Invesco S&P Emerging Markets Low Volatility ETF 0.46 25.65
FNI First Trust Chindia ETF 3.45 43.5369
ADRE Invesco BLDRS Emerging Markets 50 ADR Index Fund 0.509 38.2
FTLS First Trust Long/Short Equity ETF -0.03 63.65
ROAM Hartford Multifactor Emerging Markets ETF 0.543192 25.46
EDOG ALPS Emerging Sector Dividend Dogs ETF 0.0187 22.6601
BICK First Trust BICK Index Fund 2.66 27.93
MFEM PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF 0.61 20.9401
PBEE Invesco PureBeta FTSE Emerging Markets ETF 0.505 22.395
QEMM SPDR MSCI Emerging Markets StrategicFactors ETF 0.18314 64.0149
ISEM Invesco RAFI Strategic Emerging Markets ETF 0.17 23.435
SPGM SPDR Portfolio MSCI Global Stock Market ETF 0.131663 64.66
VMNVX Vanguard Whitehall Funds - Vanguard Global Minimum Volatility Fund 1.02 32.65
KOMP SPDR S&P Kensho New Economies Composite ETF 0.108859 49.35
RODE Hartford Multifactor Diversified International ETF 0.738386 29.65
AVEM Avantis Emerging Markets Equity ETF 0.14 65.76
RISN Inspire Tactical Large Cap ESG ETF 0.98348 26.7617
DFAE Dimensional Emerging Core Equity Market ETF 0.11208 27.91
CEMA.L iShares VII PLC - iShares MSCI EM Asia UCITS ETF USD (Acc) 0.00388 197.69
VTSNX Vanguard Total Intl Stock Idx Fund 0 138.83
AVSE Avantis Responsible Emerging Markets Equity ETF 0.14 56.0492
DEHP Dimensional Emerging Markets High Profitability ETF 0.0955513 27.3508
DFEM Dimensional Emerging Markets Core Equity 2 ETF 0.116947 28.57
DFEV Dimensional Emerging Markets Value ETF 0.153196 28.81
CSEMAS.SW iShares VII PLC - iShares MSCI EM Asia UCITS ETF USD (Acc) 0.00388 196.72
AVES Avantis Emerging Markets Value ETF 0.14 52.64
DFSE Dimensional Emerging Markets Sustainability Core 1 ETF 0.0499277 37.4
VFWAX Vanguard FTSE All-World ex-US Index Fd Admiral 0.01 39.12
VEMAX Vanguard Emerging Markets Stock Index Fund Admiral Shares 0.03 40.73
REMG SPDR Bloomberg SASB Emerging Markets ESG Select ETF 0.15 23.7787
CEBL.DE iShares VII PLC - iShares MSCI EM Asia UCITS ETF USD (Acc) 0.00421 180.1
CEA1.L iShares VII PLC - iShares MSCI EM Asia UCITS ETF USD (Acc) 0.02 15020.5
VMVFX Vanguard Global Minimum Volatility Fund Investor Cl 1.02 16.32
VTIAX Vanguard Total International Stock Index Fd Admiral 0 34.72
FDLS Inspire Fidelis Multi Factor ETF 1.10171 31.36
DFAX Dimensional World ex U.S. Core Equity 2 ETF 0.048868 27.02
GXUS Goldman Sachs ETF Trust II - Goldman Sachs MarketBeta Total International Equity ETF 0 48.0689
VEMRX Vanguard Emerging Mkts Stock Idx InsPlus 0.03 103.01
AVXC Avantis Emerging Markets ex-China Equity ETF 0.24 53.54
ERNZ TrueShares Active Yield ETF 0.09 25.35
VTPSX Vanguard Total Intl Stock Idx InstlPls 0 138.86
Unlock